AAAAAA

   
Results: 1-13 |
Results: 13
Changing incidence and survival in patients with AIDS-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART)
Authors: Chow, KU Mitrou, PS Geduldig, K Helm, EB Hoelzer, D Brodt, HR
Citation: Ku. Chow et al., Changing incidence and survival in patients with AIDS-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART), LEUK LYMPH, 41(1-2), 2001, pp. 105-116
In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine
Authors: Chow, KU Boehrer, S Geduldig, K Krapohl, A Hoelzer, D Mitrou, PS Weidmann, E
Citation: Ku. Chow et al., In vitro induction of apoptosis of neoplastic cells in low-grade non-Hodgkin's lymphomas using combinations of established cytotoxic drugs with bendamustine, HAEMATOLOG, 86(5), 2001, pp. 485-493
Treatment of aggressive, or progressing indolent peripheral T- and NK-cellneoplasias by combination of fludarabine, cyclophosphamide and doxorubicine
Authors: Weidmann, E Boehrer, S Chow, KU Engels, K Harder, L Hinz, T Janssen, O Kriener, S Rummel, MJ Siebert, R Kabelitz, D Hansmann, ML Hoelzer, D Mitrou, PS
Citation: E. Weidmann et al., Treatment of aggressive, or progressing indolent peripheral T- and NK-cellneoplasias by combination of fludarabine, cyclophosphamide and doxorubicine, ONKOLOGIE, 24(2), 2001, pp. 162-164
Influence of various cytokines on the expression of CD20 on the surface ofCLL-cells in vitro
Authors: Chow, KU Schneider, B Mitrou, PS Weidmann, E
Citation: Ku. Chow et al., Influence of various cytokines on the expression of CD20 on the surface ofCLL-cells in vitro, LEUK RES, 25(1), 2001, pp. 99-100
T-large granular lymphocyte leukaemia with natural killer cell-like cytotoxicity and expression of two different alpha- and beta-T-cell receptor chains
Authors: Boehrer, S Hinz, T Schui, DK Harder, S Chow, KU Schneider, B Hoelzer, D Mitrou, PS Weidmann, E
Citation: S. Boehrer et al., T-large granular lymphocyte leukaemia with natural killer cell-like cytotoxicity and expression of two different alpha- and beta-T-cell receptor chains, BR J HAEM, 112(1), 2001, pp. 201-203
Induction of apoptosis by 2-chloro-2 ' deoxyadenosine (2-CdA) alone and incombination with other cytotoxic drugs: Synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantrone
Authors: Chow, KU Rummel, MJ Weidmann, E Ries, J Jantschke, P Boehrer, S Pourebrahim, F Napieralski, S Stein, J Martin, H Hoelzer, D Mitrou, PS
Citation: Ku. Chow et al., Induction of apoptosis by 2-chloro-2 ' deoxyadenosine (2-CdA) alone and incombination with other cytotoxic drugs: Synergistic effects on normal and neoplastic lymphocytes by addition of doxorubicin and mitoxantrone, LEUK LYMPH, 36(5-6), 2000, pp. 559-567
Induction of apoptosis using 2 ',2 ' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphaticand myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells
Authors: Chow, KU Ries, J Weidmann, E Pourebrahim, F Napieralski, S Stieler, M Boehrer, S Rummel, MJ Stein, J Hoelzer, D Mitrou, PS
Citation: Ku. Chow et al., Induction of apoptosis using 2 ',2 ' difluorodeoxycytidine (gemcitabine) in combination with antimetabolites or anthracyclines on malignant lymphaticand myeloid cells. Antagonism or synergism depends on incubation schedule and origin of neoplastic cells, ANN HEMATOL, 79(9), 2000, pp. 485-492
Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels
Authors: Hofmann, WK Seipelt, G Ottmann, OG Kalina, U Koschmieder, S Brucher, J Frickhofen, N Klausmann, M Mitrou, PS Hoelzer, D
Citation: Wk. Hofmann et al., Effect of treatment with amifostine used as a single agent in patients with refractory anemia on clinical outcome and serum tumor necrosis factor alpha levels, ANN HEMATOL, 79(5), 2000, pp. 255-258
Cytotoxic hepatosplenic gamma delta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biological and clinical features
Authors: Weidmann, E Hinz, T Klein, S Schui, DK Harder, S Kriener, S Kabelitz, D Hoelzer, D Mitrou, PS
Citation: E. Weidmann et al., Cytotoxic hepatosplenic gamma delta T-cell lymphoma following acute myeloid leukemia bearing two distinct gamma chains of the T-cell receptor. Biological and clinical features, HAEMATOLOG, 85(10), 2000, pp. 1024-1031
Intermittent 2-hour-infusion of cladribine as first-line therapy or in first relapse of progressive advanced low-grade and mantle cell lymphomas
Authors: Rummel, MJ Chow, KU Jager, E Leimer, L Hossfeld, DK Bergmann, L Peters, HD Hansmann, ML Meyer, A Hoelzer, D Mitrou, PS
Citation: Mj. Rummel et al., Intermittent 2-hour-infusion of cladribine as first-line therapy or in first relapse of progressive advanced low-grade and mantle cell lymphomas, LEUK LYMPH, 35(1-2), 1999, pp. 129-138
Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease
Authors: Weidmann, E Baican, B Hertel, A Baum, RP Chow, KU Knupp, B Adams, S Hor, G Hoelzer, D Mitrou, PS
Citation: E. Weidmann et al., Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease, LEUK LYMPH, 34(5-6), 1999, pp. 545-551
Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: A German multicenter phase II study
Authors: Rummel, MJ Kafer, G Pfreundschuh, M Jager, E Reinhardt, U Mitrou, PS Hoelzer, D Bergmann, L
Citation: Mj. Rummel et al., Fludarabine and epirubicin in the treatment of chronic lymphocytic leukaemia: A German multicenter phase II study, ANN ONCOL, 10(2), 1999, pp. 183-188
Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse
Authors: Rummel, MJ Chow, KU Jager, E Hossfeld, DK Bergmann, L Peters, HD Hansmann, ML Meyer, A Hoelzer, D Mitrou, PS
Citation: Mj. Rummel et al., Treatment of mantle-cell lymphomas with intermittent two-hour infusion of cladribine as first-line therapy or in first relapse, ANN ONCOL, 10(1), 1999, pp. 115-117
Risultati: 1-13 |